Navigation Links
New Chief Executive Reports Q1 Results and Sets out Strategy for Growth
Date:5/2/2013

mpared to Q1 2012, primarily as a result of higher prescription demand (up 6%) and the effect of a price increase taken since Q1 2012. Shire also experienced further destocking in the retail channel which was offset by the positive impact of some shipment slippage from Q4 2012.

ELAPRASE- Hunter syndrome

Product sales from ELAPRASE in Q1 2013 were down 9% compared to Q1 2012 due to the impact of the timing of large orders to certain markets which order less frequently. The underlying number of patients being treated with ELAPRASE continues to grow.

REPLAGAL - Fabry disease

REPLAGAL sales for the quarter were down 15% primarily due to the impact of ordering patterns in Latin America and lower volumes in Europe, where the impact of increased competition outweighed the continued growth in new naïve patients. On a global basis, total patient numbers continue to show good long term growth.

LIALDA/MEZAVANT - Ulcerative colitis

Product sales for LIALDA/MEZAVANT increased (up 12%) in Q1 2013 primarily due to higher market share in the US and the effect of a price increase taken since Q1 2012. These positive factors were to a lesser extent offset by the effect of higher US sales deductions and higher destocking at the retail level.

VPRIV - Gaucher disease

Growth in VPRIV product sales (up 14%) in Q1 2013 was driven by the continued growth in the number of patients on therapy.

INTUNIV - ADHD

The strong growth in INTUNIV product sales (up 13%) in Q1 2013 was driven by growth in US prescription demand (up 12%) and the effect of price increases taken since Q1 2012. These positive factors were partially offset by the effect of destocking in Q1 2013 as compared to slight stocking in Q1 2012.

PENTASA - Ulcerative colitis

PENTASA product sales (up 8%) benefited from price increases taken since Q1 2012, the impact of which was moderated by a smal
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
3. Nephros Appoints John C. Houghton as President and Chief Executive Officer
4. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
5. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
6. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
7. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
8. Neal K. Long appointed as Chief Executive Officer at Cardiac Science
9. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... NEW YORK , June 3, 2015 ... grow at a CAGR of 10.1% from 2014 to ... market is driven by factors, such as the rising ... and growing technology advancements. However, factors such as lack ... the growth of this market. In ...
(Date:6/3/2015)... 3, 2015  Diomics today announced that Stephen ... has joined the company,s board of directors, effective immediately. ... Project and Clinical Professor at the Lyndon B. Johnson ... at Austin. "Steve brings an incredible ... years as a member of CIA,s clandestine service, including ...
(Date:6/3/2015)... DUBLIN , June 3, 2015  Actavis plc (NYSE: ... that Brent Saunders , CEO and President of Actavis, ... at the Goldman Sachs 36th Annual Global Healthcare Conference in ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO The presentation ... a.m. Pacific Time at the Terranea Resort, Rancho ...
Breaking Medicine Technology:Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 2Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2
... Serina Therapeutics, Inc. President and CEO Randall Moreadith, MD, PhD, ... financing round to advance its lead oncology candidate SER-203 into ... "We are pleased to report to our existing and ... launched in late 2010. This is a very significant milestone ...
... (Nasdaq: ENDP ) today announced that Alan Levin, ... corporate overview at the Goldman Sachs Global Healthcare Conference on ... will be held at the Terranea Resort in Rancho Palos ... of the presentation will be available on the company,s website ...
Cached Medicine Technology:Serina Therapeutics, Inc. Closes $9.5 Million Financing Round 2
(Date:6/3/2015)... June 03, 2015 AvePoint, ... and devices, announced today that it has won the ... and Content. The company was honored among a global ... in innovation and implementation of customer solutions based on ... of the Year Awards – including the 2014 Microsoft ...
(Date:6/3/2015)... Follow us on LinkedIn ... disease treatment on account of their better mode of ... as rheumatoid arthritis. The industry is expected to witness ... molecule drugs to biopharmaceuticals over the coming years. The ... gene therapies, and recombinant proteins has attracted industry players ...
(Date:6/3/2015)... Newark, New Jersey (PRWEB) June 03, 2015 ... chosen by Diversity MBA Magazine as one of the nation’s ... ranked Horizon BCBSNJ No. 6 among its national list of ... ranked Horizon BNCBSNJ as the No. 1 Regional Company. ... been honored by Diversity MBA Magazine for its diverse workplace ...
(Date:6/3/2015)... 03, 2015 Justina Molzon, MS Pharm, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... Excellence in Service Award that recognizes the “Member of ... DIA volunteer and who has contributed to the advancement ...
(Date:6/3/2015)... Researchers at the University of Western Australia ... the tried-and-true marker mesothelin is the best option available. ... research. Click here to read it now. ... Related Diseases say, even though a mesothelin test can ... to fibulin-3 for identifying mesothelioma. , “Preliminary results ...
Breaking Medicine News(10 mins):Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2
... , FRIDAY, Nov. 9 (HealthDay News) -- A drug called ... patients with chronic active gout. , That,s according to a ... who had gout for an average of 13 years. , ... VA Medical Center and University of California, San Diego. , ...
... robots.,It sounds like the theme of a cartoon ... and innovative research being conducted at the University ... cognitive,development of infants with special needs., Two ... professor of,physical therapy, and Sunil Agrawal, professor of ...
... Nov. 9 World Diabetes Day is,November 14, ... celebrating the,successful launch of the 12-Day Stopping Diabetes ... treatments for type 2 diabetes, this,program focuses on ... its patients. Dr. Stuart Seale, medical director ...
... Washington, DC November 9, 2007 Shire plc ... biopharmaceutical company, yesterday announced results of a national survey ... to12 year old childs once-daily Attention Deficit Hyperactivity Disorder ... survey findings report the perceptions of 500 parents of ...
... DAKAR, Senegal -- The National Academy of Sciences and ... of the African Science Academy Development Initiative (ASADI), a ... to provide their nations with evidence-based advice. The ... the value of this advice in informing decisions about ...
... Bulletin Board:,NTRZ), a health science company and a ... that it will release its third quarter financial,results ... Management will host the conference call on ... 2007 third quarter financial results and provide,management updates. ...
Cached Medicine News:Health News:Babies Driving Robots at University 2Health News:Babies Driving Robots at University 3Health News:Babies Driving Robots at University 4Health News:Babies Driving Robots at University 5Health News:Babies Driving Robots at University 6Health News:New Sedona Stopping Diabetes Program 2Health News:Parents survey: Perceptions of the duration of their child's ADHD medication 2Health News:Safe water is theme of African science academies conference in Senegal 2Health News:NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14 2
... Prep Pads prepares the skin for improved ... dry, it leaves a thin film on ... surface and a barrier for natural body ... a dressing or tape. Skin Protectant is ...
... 70% USP and 10% Acetone Alcohol Prep ... antiseptic, anti-infective prior to administering injections. Acetone ... and fats from the skin. They are ... to contain a consistent amount of alcohol ...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Medicine Products: